News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mehra Uneek
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Mehra Uneek (See Remarks) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Granted 229,634 options to buy
@ $12.73, valued at
$2.9M
|
|
| 09/26/2023 |
3
| Mehra Uneek (See Remarks) has filed a Form 3 on 4D Molecular Therapeutics, Inc. |
| 03/10/2023 |
4
| Mehra Uneek (Principal Financial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 20,724 shares
@ $0
Disposed/sold 181,972 shares
@ $0
Disposed/sold 165,192 options to buy
@ $21.83, valued at
$3.6M
Disposed/sold 111,111 rights
@ $0 |
|
| 12/20/2022 |
4
| Mehra Uneek (Principal Financial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 2,241 shares
@ $26.75, valued at
$59.9k
|
|
| 09/20/2022 |
4
| Mehra Uneek (Principal Financial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 9,243 shares
@ $18.86, valued at
$174.3k
|
|
| 04/19/2022 |
4
| Mehra Uneek (Principal Financial Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 111,111 shares
@ $0 |
|
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|